Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Atlassian
TEAM
|
$437M |
| 2 |
AbbVie
ABBV
|
$380M |
| 3 |
Workday
WDAY
|
$366M |
| 4 |
Synopsys
SNPS
|
$323M |
| 5 |
Advanced Micro Devices
AMD
|
$286M |
Top Sells
| 1 |
Adobe
ADBE
|
$1.71B |
| 2 |
Apple
AAPL
|
$984M |
| 3 |
Boston Scientific
BSX
|
$642M |
| 4 |
Microsoft
MSFT
|
$599M |
| 5 |
Texas Instruments
TXN
|
$491M |
Sector Composition
| 1 | Technology | 31.62% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Xencor
XNCR
$610M
| $284K | ﹤0.01% |
10,627
+2
| +0% | +$53 |
|
|
FLME.U
2252
DELISTED
Flame Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one Warrant
FLME.U
| $284K | ﹤0.01% |
28,757
| – | – |
|
2253
Hovnanian Enterprises
HOV
$908M
| $283K | ﹤0.01% |
4,787
-90
| -2% | -$5.32K |
|
2254
LendingClub
LC
$1.9B
| $283K | ﹤0.01% |
17,903
+10
| +0.1% | +$158 |
|
2255
PROS Holdings
PRO
$746M
| $283K | ﹤0.01% |
8,521
+1
| +0% | +$33 |
|
|
TGI
2256
DELISTED
Triumph Group
TGI
| $283K | ﹤0.01% |
11,217
+1
| +0% | +$25 |
|
2257
Healthcare Services Group
HCSG
$1.15B
| $282K | ﹤0.01% |
15,170
+1
| +0% | +$19 |
|
2258
Nelnet
NNI
$4.66B
| $282K | ﹤0.01% |
3,312
+1
| +0% | +$85 |
|
2259
TriMas Corp
TRS
$1.57B
| $282K | ﹤0.01% |
8,764
| – | – |
|
2260
Vanguard FTSE Emerging Markets ETF
VWO
$97.2B
| $281K | ﹤0.01% |
6,090
-37,154
| -86% | -$1.71M |
|
|
SLCA
2261
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $281K | ﹤0.01% |
15,075
| – | – |
|
2262
ADT
ADT
$7.13B
| $280K | ﹤0.01% |
36,943
-3,120
| -8% | -$23.6K |
|
|
ADAM
2263
Adamas Trust, Inc. Common Stock
ADAM
$669M
| $280K | ﹤0.01% |
19,178
+3
| +0% | +$44 |
|
2264
Cassava Sciences
SAVA
$104M
| $280K | ﹤0.01% |
+7,532
| New | +$280K |
|
2265
O-I Glass
OI
$1.97B
| $278K | ﹤0.01% |
21,078
-10,880
| -34% | -$143K |
|
2266
Core Laboratories
CLB
$592M
| $277K | ﹤0.01% |
+8,771
| New | +$277K |
|
2267
Cerence
CRNC
$399M
| $277K | ﹤0.01% |
7,665
+8
| +0.1% | +$289 |
|
2268
Unisys
UIS
$277M
| $277K | ﹤0.01% |
12,817
+1
| +0% | +$22 |
|
|
PTRA
2269
DELISTED
Proterra Inc. Common Stock
PTRA
| $277K | ﹤0.01% |
36,953
+44
| +0.1% | +$330 |
|
2270
Liberty Energy
LBRT
$1.7B
| $276K | ﹤0.01% |
18,627
+100
| +0.5% | +$1.48K |
|
|
CGC
2271
Canopy Growth
CGC
$456M
| $275K | ﹤0.01% |
3,620
-448
| -11% | -$34K |
|
2272
Celldex Therapeutics
CLDX
$1.52B
| $275K | ﹤0.01% |
8,081
+2
| +0% | +$68 |
|
2273
Enova International
ENVA
$3.01B
| $275K | ﹤0.01% |
7,258
-2,889
| -28% | -$109K |
|
2274
Veeco
VECO
$1.47B
| $275K | ﹤0.01% |
10,098
+2
| +0% | +$54 |
|
2275
Domo
DOMO
$588M
| $274K | ﹤0.01% |
5,429
-20,084
| -79% | -$1.01M |
|